Lucas Wilken

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Venues

Viruses

Vaccines

Journal of virology

Emerging microbes & infections

Stiftung Tierärztliche Hochschule Hannover

Erasmus MC (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Stiftung Tierärztliche Hochschule Hannover Oct 01 2019

Germany

PhD Student :: Research Center for Emerging Infections and Zoonoses (RIZ)

Education History

Erasmus MC Sep 04 2017 - Aug 30 2019

Netherlands

MSC :: Postgraduate School Molecular Medicine

Robert Gordon University

United Kingdom

BSC :: School of Pharmacy and Life Sciences

Hochschule Bonn-Rhein-Sieg - Campus Rheinbach

Germany

BSC :: Fachbereich Angewandte Naturwissenschaften

Publications

Chittappen Kandiyil Prajeeth, Isabel Zdora, Giulietta Saletti, Julia Friese, Thomas Gerlach, Lucas Wilken, Jana Beicht, Mareike Kubinski, Christina Puff, Wolfgang Baumgärtner, Jeroen Kortekaas, Paul J Wichgers Schreur, Albert D M E Osterhaus, Guus F Rimmelzwaan
Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice. Emerging microbes & infections 13 (1) (2024)
Dominik Kiemel, Ann-Sophie Helene Kroell, Solène Denolly, Uta Haselmann, Jean-François Bonfanti, Jose Ignacio Andres, Brahma Ghosh, Peggy Geluykens, Suzanne J F Kaptein, Lucas Wilken, Pietro Scaturro, Johan Neyts, Marnix Van Loock, Olivia Goethals, Ralf F W Bartenschlager
Pan-serotype dengue virus inhibitor JNJ-A07 targets NS4A-2K-NS4B interaction with NS2B/NS3 and blocks replication organelle formation. Nature communications 15 (1) (2024)
Lucas Wilken, Guus F Rimmelzwaan, Husni Elbahesh
The Raf kinase inhibitors Dabrafenib and Regorafenib impair Zika virus replication via distinct mechanisms. Journal of virology 98 (8) (2024)
Lucas Wilken, Guus F Rimmelzwaan, Husni Elbahesh
The Raf kinase inhibitors Dabrafenib and Regorafenib impair Zika virus replication via distinct mechanisms. Journal of virology 98 (8) (2024)
Lucas Wilken, Guus F Rimmelzwaan, Husni Elbahesh
The Raf kinase inhibitors Dabrafenib and Regorafenib impair Zika virus replication via distinct mechanisms. Journal of virology 98 (8) (2024)
Dominik Kiemel, Ann-Sophie Helene Kroell, Solène Denolly, Uta Haselmann, Jean-François Bonfanti, Jose Ignacio Andres, Brahma Ghosh, Peggy Geluykens, Suzanne J F Kaptein, Lucas Wilken, Pietro Scaturro, Johan Neyts, Marnix Van Loock, Olivia Goethals, Ralf F W Bartenschlager
Pan-serotype dengue virus inhibitor JNJ-A07 targets NS4A-2K-NS4B interaction with NS2B/NS3 and blocks replication organelle formation. Nature communications 15 (1) (2024)
Chittappen Kandiyil Prajeeth, Isabel Zdora, Giulietta Saletti, Julia Friese, Thomas Gerlach, Lucas Wilken, Jana Beicht, Mareike Kubinski, Christina Puff, Wolfgang Baumgärtner, Jeroen Kortekaas, Paul J Wichgers Schreur, Albert D M E Osterhaus, Guus F Rimmelzwaan
Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice. Emerging microbes & infections 13 (1) (2024)
Chittappen Kandiyil Prajeeth, Isabel Zdora, Giulietta Saletti, Julia Friese, Thomas Gerlach, Lucas Wilken, Jana Beicht, Mareike Kubinski, Christina Puff, Wolfgang Baumgärtner, Jeroen Kortekaas, Paul J Wichgers Schreur, Albert D M E Osterhaus, Guus F Rimmelzwaan
Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice. Emerging microbes & infections 13 (1) (2024)
Dominik Kiemel, Ann-Sophie Helene Kroell, Solène Denolly, Uta Haselmann, Jean-François Bonfanti, Jose Ignacio Andres, Brahma Ghosh, Peggy Geluykens, Suzanne J F Kaptein, Lucas Wilken, Pietro Scaturro, Johan Neyts, Marnix Van Loock, Olivia Goethals, Ralf F W Bartenschlager
Pan-serotype dengue virus inhibitor JNJ-A07 targets NS4A-2K-NS4B interaction with NS2B/NS3 and blocks replication organelle formation. Nature communications 15 (1) (2024)
Lucas Wilken, Guus F Rimmelzwaan, Husni Elbahesh
The Raf kinase inhibitors Dabrafenib and Regorafenib impair Zika virus replication via distinct mechanisms. Journal of virology (2024)
Lucas Wilken, Sonja Stelz, Ayse Agac, Gerd Sutter, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice. Vaccines 11 (4) (2023)
Lucas Wilken, Sonja Stelz, Ayse Agac, Gerd Sutter, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice. Vaccines 11 (4) (2023)
Lucas Wilken, Sonja Stelz, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Transient Blockade of Type I Interferon Signalling Promotes Replication of Dengue Virus Strain D2Y98P in Adult Wild-Type Mice. Viruses 15 (4) (2023)
Lucas Wilken, Sonja Stelz, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Transient Blockade of Type I Interferon Signalling Promotes Replication of Dengue Virus Strain D2Y98P in Adult Wild-Type Mice. Viruses 15 (4) (2023)
Lucas Wilken, Sonja Stelz, Ayse Agac, Gerd Sutter, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice. Vaccines 11 (4) (2023)
Lucas Wilken, Sonja Stelz, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Transient Blockade of Type I Interferon Signalling Promotes Replication of Dengue Virus Strain D2Y98P in Adult Wild-Type Mice. Viruses 15 (4) (2023)
Lucas Wilken, Sonja Stelz, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Transient Blockade of Type I Interferon Signalling Promotes Replication of Dengue Virus Strain D2Y98P in Adult Wild-Type Mice. Viruses 15 (4) (2023)
Lucas Wilken, Sonja Stelz, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Transient Blockade of Type I Interferon Signalling Promotes Replication of Dengue Virus Strain D2Y98P in Adult Wild-Type Mice. Viruses 15 (4) (2023)
Lucas Wilken, Sonja Stelz, Ayse Agac, Gerd Sutter, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice. Vaccines 11 (4) (2023)
Lucas Wilken, Guus F Rimmelzwaan
Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design? Pathogens (Basel, Switzerland) 9 (6) (2020)
Lucas Wilken, Anne McPherson
Application of camelid heavy-chain variable domains (VHHs) in prevention and treatment of bacterial and viral infections. International reviews of immunology 37 (1) (2017)

Lucas Wilken.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Lucas Wilken